Beta Bionics, Inc. · NASDAQ:BBNX
Hopman Mark sold 370 Beta Bionics, Inc. shares (Form 4)
Traded Oct 1, 2026 · Filed Oct 5, 2026
On Oct 1, 2026, Hopman Mark (Chief Commercial Officer) sold 370 Beta Bionics, Inc. shares at US$18.96 for US$7,015, leaving 56,109 shares. Filed Oct 5, 2026 (Form 4).
- Sold
- 370 shares
- Price
- US$18.96
- Value
- US$7,015
- Holding after
- 56,109 shares
- Trading plan
- No
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Common Stock | Sale | 370 | US$18.96 | 56,109 | Direct |
Source
Related
- Beta Bionics, Inc.
- Hopman Mark
- Beta Bionics, Inc. shareholders
- Form 4 · Hopman Mark · Oct 16, 2026
- Form 4/A · Hopman Mark · Sep 18, 2026
- Form 4 · Hopman Mark · Sep 17, 2026
- Form 4 · Hopman Mark · Sep 15, 2026
- Form 4 · Hopman Mark · Sep 10, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Oct 7, 2026
- Form 4 · Jones Christy · Sep 23, 2026
- Form 4 · Mensinger Mike · Sep 17, 2026
- Form 4 · Saint Sean · Sep 4, 2026
- Form 4 · Hopman Mark · Sep 3, 2026